Specificity between the anti-aggregatory actions of prostacyclin, prostaglandin E1 and D2 on platelets.
Whittle
B J
BJ
Hamid
S
S
Lidbury
P
P
Rosam
A C
AC
D000262:Adenylyl Cyclases / Q000097:blood; D000527:Alprostadil / Q000097:blood / Q000494:pharmacology*; D000818:Animals; D002462:Cell Membrane / Q000378:metabolism; D011464:Epoprostenol / Q000097:blood / Q000494:pharmacology* / Q000031:analogs & derivatives; D006801:Humans; D006827:Hydantoins / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects*; D015230:Prostaglandin D2; D011457:Prostaglandins D / Q000037:antagonists & inhibitors / Q000097:blood / Q000494:pharmacology*; D011465:Prostaglandins, Synthetic / Q000494:pharmacology; D011869:Radioligand Assay; D044006:Receptors, Epoprostenol; D011971:Receptors, Immunologic; D011982:Receptors, Prostaglandin / Q000378:metabolism; D018078:Receptors, Prostaglandin E; D013045:Species Specificity; D013329:Structure-Activity Relationship
D006827:Hydantoins; D011457:Prostaglandins D; D011465:Prostaglandins, Synthetic; D044006:Receptors, Epoprostenol; D011971:Receptors, Immunologic; D011982:Receptors, Prostaglandin; D018078:Receptors, Prostaglandin E; C026678:carboprostacyclin; C030669:BW 245C; D011464:Epoprostenol; D000262:Adenylyl Cyclases; D000527:Alprostadil; D015230:Prostaglandin D2; C036293:prostaglandin D2 receptor